CrushSCI.com
68.8Average days
73.5Median days
19Fastest days
120Longest days
622025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

72 days

Population Reference Data in the Molecular Diagnosis of Pathogenic CAPN3 Variants: Contextual Evidence and Interpretive Limits

Authors
Meghan H. Carr; Ehab Y. Harahsheh; Shaymaa Shurrab; Bukola A. Olarewaju; Mayowa A. OsundijiShow moreShow less
Affiliations
1. Omics Curation Ltd., Hayes, UK; 2. Department of Neurology, Mayo Clinic, Phoenix, USA; 3. Division of Genetics/Metabolics, McMaster University, Hamilton, Canada; 4. School of Science and Engineering, University of Dundee, Dundee, UK; 5. Department of Clinical Genomics, Mayo Clinic, Phoenix, USA; 6. Prism Biomedical Consulting, Niagara Falls, CanadaShow moreShow less
Source PDF DOI Publisher page
35 days

Orca-T: First Approval

Authors
Hannah A. BlairShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
Source PDF DOI Publisher page
82 days

Rapid Ex Vivo Visualization of Laryngeal Tumors Using a Sprayable pH-Activatable Fluorophore

Authors
Daan G. J. Linders; Sebastiaan W. R. Dalmeijer; Bo E. Zweedijk; Hamed Abbasi; Danielle Boldewijn; Sjors A. Koppes; Bernd Kremer; Jacobus Burggraaf; Denise E. Hilling; Joost R. van der Vorst; Jinhui Ser; Satoshi Kashiwagi; Maged Henary; Jeroen C. Jansen; Alexander L. Vahrmeijer; Hak Soo Choi; Stijn KeereweerShow moreShow less
Affiliations
1. Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands; 2. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; 3. Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 4. Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 5. Centre for Human Drug Research, Leiden, The Netherlands; 6. Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands; 7. Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 8. Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA; 9. Center for Inflammation Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA; 10. Department of Chemistry, Center of Diagnostics and Therapeutics, Georgia State University, Atlanta, USAShow moreShow less
Source PDF DOI Publisher page
90 days

Bridging Biomarker Testing to Biomarker-Driven Targeted Therapy: Real-World ESR1 Mutation Testing Patterns and Prevalence in ER+, HER2− Metastatic Breast Cancer

Authors
Chi-Yin Liao; Jincy John; Precious Anyanwu; Manali A. Bhave; Francois-Clement Bidard; Tyler Marquart; Francisco Sapunar; Aarti Chawla; Lindsay A. WilliamsShow moreShow less
Affiliations
1. Eli Lilly and Company, Indianapolis, USA; 2. Winship Cancer Institute of Emory University, Atlanta, USA; 3. Institut Curie, Paris, FranceShow moreShow less
Source PDF DOI Publisher page
19 days

Anbalcabtagene Autoleucel: First Approval

Authors
Arnold LeeShow moreShow less
Affiliations
1. Springer Nature, Auckland 0754, New ZealandShow moreShow less
Source PDF DOI Publisher page
80 days

Development of a Point-of-Care Recombinase Polymerase Amplification Assay for Detection of Neisseria gonorrhoeae and Ceftriaxone-Resistance Associated penA Allele 60.001

Authors
Xia Sun; Ying Fu; Yi Liu; Qiongyao Liu; Luxia Chen; Jiang Zhu; Xu’ai Lin; Hao Cheng; Stijn van der VeenShow moreShow less
Affiliations
1. Department of Infectious Diseases of the Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Microbiology, School of Medicine, Zhejiang University, Hangzhou, China; 2. Zhejiang University-University of Edinburgh Institute, School of Medicine, Zhejiang University, Haining, China; 3. Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; 4. Amp-Future Biotech, Changzhou, China; 5. Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; 6. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Molecular Diagnosis & Therapy take to review a manuscript?

As of 2026-11-18, CrushSCI has 18 complete review records for Molecular Diagnosis & Therapy. The fastest paper went from submission to acceptance in 19 days (Anbalcabtagene Autoleucel: First Approval, received 2026-07-10, accepted 2026-07-29); the slowest took 120 days. The average is 68.8 days and the median is 73.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.